| [1] |
Claudio Ronco, 张凌, 陆任华, 等. 重症肾脏替代治疗和血液净化技术的标准化术语命名[J]. 华西医学, 2018, 33(7):782-796.
|
|
Ronco C, Zhang L, Lu RH, et al. Nomenclature for renal replacement therapy and blood purification techniques in critically ill patients[J]. West China Med J, 2018, 33(7):782-796.
|
| [2] |
Rabindranath K, Adams J, MacLeod AM, et al. Intermittent versus continuous renal replacement therapy for acute renal failure in adults[J]. Cochrane Database Syst Rev, 2007(3):CD003773.
|
| [3] |
Schneider AG, Bellomo R, Bagshaw SM, et al. Choice of renal replacement therapy modality and dialysis dependence after acute kidney injury:a systematic review and meta-analysis[J]. Intensive Care Med, 2013, 39(6):987-997.
doi: 10.1007/s00134-013-2864-5
pmid: 23443311
|
| [4] |
Monti G, Herrera M, Kindgen-Milles D, et al. The DOse RE-sponse multicentre international collaborative initiative(DO-RE-MI)[J]. Contrib Nephrol, 2007, 156:434-443.
pmid: 17464155
|
| [5] |
Khwaja A. KDIGO clinical practice guidelines for acute kidney injury[J]. Nephron Clin Pract, 2012, 120(4):c179-c184.
|
| [6] |
查丽玲, 周松, 江榕. ICU行枸橼酸抗凝CRRT病人非计划性下机影响因素研究[J]. 护理研究, 2018, 32(18):2926-2930.
|
|
Zha LL, Zhou S, Jiang R. Study on influencing factors of unplanned downtime of citrate anticoagulation CRRT in ICU patients[J]. Chin Nurs Res, 2018, 32(18):2926-2930.
|
| [7] |
李克佳, 胡军, 苏琳, 等. 重症患者连续性肾脏替代治疗非计划下机的相关因素研究[J]. 中国血液净化, 2020, 19(9):645-648.
|
|
Li KJ, Hu J, Su L, et al. Related factors of unexpected interruption of continuous renal replacement therapy in critical care patients[J]. Chin J Blood Purif, 2020, 19(9):645-648.
|
| [8] |
胡雁, 郝玉芳. 循证护理学[M]. 2版. 北京: 人民卫生出版社, 2018.
|
|
Hu Y, Hao YF. Evidence-based nursing[M]. 2nd ed. Beijing: People’s Medical Publishing House, 2018.
|
| [9] |
Liu SY, Xu SY, Yin L, et al. Management of regional citrate anticoagulation for continuous renal replacement therapy:guideline recommendations from Chinese emergency medical doctor consensus[J]. Mil Med Res, 2023, 10(1):23.
|
| [10] |
中华医学会肾脏病学分会专家组. 连续性肾脏替代治疗的抗凝管理指南[J]. 中华肾脏病杂志, 2022, 38(11):1016-1024.
|
|
Chinese Medical Association Nephrology Society Expert Group. Guidelines for the anticoagulant management of continuous renal replacement therapy[J]. Chin J Nephrol, 2022, 38(11):1016-1024.
doi: 10.3760/cma.j.cn441217-20220620-00149
|
| [11] |
Harth A, Willam C, Jörres A. S3-leitlinie nierenersatztherapie in der intensivmedizin[J]. Die Nephrol, 2025, 20(6):454-461.
doi: 10.1007/s11560-025-00880-0
|
| [12] |
共识专家组. 抗凝技术在危重症肾脏替代治疗应用的中国专家共识(2023年版)[J]. 中华肾脏病杂志, 2023, 39(2):155-164.
doi: 10.3760/cma.j.cn441217-20220809-00815
|
|
Consensus Expert Group. Chinese expert consensus on the application of anticoagulant technology in renal replacement therapy for critical patients(2023)[J]. Chin J Nephrol, 2023, 39(2):155-164.
doi: 10.3760/cma.j.cn441217-20220809-00815
|
| [13] |
李燕, 莫伟, 葛静萍. 抗凝剂皮下注射护理规范专家共识[J]. 介入放射学杂志, 2019, 28(8):709-716.
|
|
Li Y, Mo W, Ge JP, et al. Expert consensus on nursing standards for subcutaneous injection of anticoagulant agents[J]. J Interv Radiol, 2019, 28(8):709-716.
|
| [14] |
四川省国际交流促进会肾脏分会专家组. 连续性肾脏替代治疗医院感染防控专家共识[J]. 华西医学, 2023, 38(7):961-968.
|
|
Nephrology Branch of Sichuan International Medical Exchange & Promotion Association. Expert consensus on hospital infection prevention and control in continuous renal replacement therapy[J]. West China Med J, 2023, 38(7):961-968.
|
| [15] |
中国医师协会体外生命支持专业委员会. 成人体外膜氧合循环辅助专家共识[J]. 中华重症医学电子杂志(网络版), 2018, 4(2):114-122.
|
|
Chinese Medical Association Extracorporeal Life Support Professional Committee. Expert consensus on assisting extracorporeal membrane oxygenation circulation in adults[J]. Chin J Crit Care Intensive Care Med Electron Ed, 2018, 4(2):114-122.
|
| [16] |
肇冬梅, 马晓春. 血液净化:抗凝的策略[J]. 中国实用内科杂志, 2023, 43(12):996-999.
|
|
Zhao DM, Ma XC. Blood purification:strategies for anticoagulation[J]. Chin J Pract Intern Med, 2023, 43(12):996-999.
|
| [17] |
Legrand M, Tolwani A. Anticoagulation strategies in continuous renal replacement therapy[J]. Semin Dial, 2021, 34(6):416-422.
doi: 10.1111/sdi.v34.6
|
| [18] |
LaMonte MP, Brown PM, Hursting MJ. Alternative parenteral anticoagulation with argatroban,a direct thrombin inhibitor[J]. Expert Rev Cardiovasc Ther, 2005, 3(1):31-41.
doi: 10.1586/14779072.3.1.31
pmid: 15723573
|
| [19] |
Arepally GM. Heparin-induced thrombocytopenia[J]. Blood, 2017, 129(21):2864-2872.
doi: 10.1182/blood-2016-11-709873
pmid: 28416511
|
| [20] |
Gameiro J, Jorge S, Lopes JA. Haemodialysis-related-heparin-induced thrombocytopenia:case series and literature review[J]. Nefrología Engl Ed, 2018, 38(5):551-557.
|
| [21] |
Koster A, Ljajikj E, Faraoni D. Traditional and non-traditional anticoagulation management during extracorporeal membrane oxygenation[J]. Ann Cardiothorac Surg, 2019, 8(1):129-136.
doi: 10.21037/acs
|
| [22] |
Schilder L, Nurmohamed SA, Bosch FH, et al. Citrate anticoagulation versus systemic heparinisation in continuous venovenous hemofiltration in critically ill patients with acute kidney injury:a multi-center randomized clinical trial[J]. Crit Care, 2014, 18(4):472.
doi: 10.1186/s13054-014-0472-6
|
| [23] |
Stucker F, Ponte B, Tataw J, et al. Efficacy and safety of citrate-based anticoagulation compared to heparin in patients with acute kidney injury requiring continuous renal replacement therapy:a randomized controlled trial[J]. Crit Care, 2015, 19(1):91.
doi: 10.1186/s13054-015-0822-z
|
| [24] |
GB 15982—2012医院消毒卫生标准[S].
|
|
GB 15982-2012 Hospital Disinfection and Sanitation Standards[S].
|
| [25] |
国家卫生和计划生育委员会. 重症监护病房医院感染预防与控制规范WS/T 509:2016[J]. 中国感染控制杂志, 2017, 16(2):191-194.
|
|
National Health and Family Planning Commission. (2016).Regulation for prevention and control of healthcare associated infection in intensive care unit[J]. Chin J Infect Control, 2017, 16(2):191-194.
|
| [26] |
WS/T 313-2019医务人员手卫生规范[S/OL]. http://wwww nhc.gov.cn/wjw/s9496/202002/dbd143c44abd4de8b59a235feef7d75e.shtml.
|
|
WS/T 3132019 Hand Hygiene Guidelines for Medical Person-nel[S/OL]. http://wwww nhc.gov.cn/wjw/s9496/202002/dbd143c44abd4de8b59a235feef7d75e.shtml.
|
| [27] |
卫生部. 医院隔离技术规范[J]. 中华医院感染学杂志, 2009, 19(13).
|
|
Chinese Medical Association Extracorporeal Life Support Professional Committee. (2018). Technical specification for hospital isolation[J]. Chin J Nosocomioly,2009, 19(13).
|
| [28] |
Miyatake Y, Makino S, Kubota K, et al. Association between intra-circuit activated clotting time and incidence of bleeding complications during continuous renal replacement therapy using nafamostat mesilate:a retrospective pilot observational study[J]. Kobe J Med Sci, 2017, 63(1):E30-E36.
|
| [29] |
Akhoundi A, Singh B, Vela M, et al. Incidence of adverse events during continuous renal replacement therapy[J]. Blood Purif, 2015, 39(4):333-339.
doi: 10.1159/000380903
|
| [30] |
刘大为, 杨荣利, 陈秀凯. 重症血液净化[M]. 北京: 人民卫生出版社, 2017.
|
|
Liu DW, Yang RL, Chen XK. CCBP critical care blood purification[M]. Beijing: People’s Medical Publishing House, 2017.
|
| [31] |
陈香梅. 血液净化标准操作规程[M]. 北京: 人民卫生出版社, 2021.
|
|
Chen XM. Standard operating procedures for blood purificatio. People’s Medical Publishing House, 2021.
|
| [32] |
Liu SY, Xu SY, Yin L, et al. Management of regional citrate anticoagulation for continuous renal replacement therapy:guideline recommendations from Chinese emergency medical doctor consensus[J]. Mil Med Res, 2023, 10(1):23.
|
| [33] |
王庆云, 肖素飞, 卢嫦清, 等. 连续性肾脏替代治疗嵌入体外膜肺氧合管路连接方式的研究进展[J]. 中华护理杂志, 2022, 57(7):811-816.
doi: 10.3761/j.issn.0254-1769.2022.07.007
|
|
Wang QY, Xiao SF, Lu CQ, et al. Continuous renal replacement therapy embedded in extracorporeal membrane oxygenation:a review[J]. Chin J Nurs, 2022, 57(7):811-816.
|
| [34] |
唐晓, 孙兵. 体外膜肺氧合抗凝管理进展[J]. 内科急危重症杂志, 2022, 28(5):357-360.
|
|
Tang X, Sun B. Progresses in anticoagulation management of extracorporeal membrane oxygenation[J]. J Intern Intensive Med, 2022, 28(5):357-360.
|
| [35] |
李镇洲, 万建新. 局部枸橼酸抗凝在连续性肾脏替代治疗中的应用要点[J]. 中国血液净化, 2021, 20(12):797-800.
|
|
Li ZZ, Wan JX. Application of local citrate anticoagulation in continuous renal replacement therapy[J]. Chin J Blood Purif, 2021, 20(12):797-800.
|